<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03170427</url>
  </required_header>
  <id_info>
    <org_study_id>18/CE/2012</org_study_id>
    <nct_id>NCT03170427</nct_id>
  </id_info>
  <brief_title>Impedance Cardiography as Tool for Continuous Hemodynamic Monitoring During Cesarean Section</brief_title>
  <official_title>Impedance Cardiography as Tool for Continuous Hemodynamic Monitoring During Cesarean Section: Randomized, Prospective Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Foggia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Foggia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Impedance Cardiography (ICG) is a non-invasive tool for continuous hemodynamic monitoring.
      Aims of our study is to assess the utility of ICG to evaluate the hemodynamic impact of 6 mg
      (GL6) vs 8 mg (GL8) levobupivacaine combined with fentanyl in healthy patients undergoing
      elective cesarean section; secondary, to compare the duration and quality of analgesia and
      anesthesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On arrival in the recovery room the ICG non-invasive blood pressure cuff will be placed on
      the left arm, two sensors will be placed above the clavicle on each side of the neck, and two
      sensors will bw placed on either side of the thorax at midaxillary line corresponding to the
      level of the xiphoid process. Using a computer- generated sequence of numbers, patients will
      be randomly allocated in one of the two groups: 6 mg (1.6 mL) levobupivacaine + 20 µg
      fentanyl (GL6 group) or 8 mg (2 mL) levobupivacaine + 20 µg fentanyl (GL8 group). Continuous
      spinal epidural anesthesia (CSE) will be performed with patient in sitting position: a
      18-gauge Tuohy needle will be inserted into the L2-L3 interspace using the loss of resistance
      of saline technique to identify the epidural space; a 27-gauge Withacre spinal needle will be
      then placed through the Tuohy needle until the dura mater wwill be punctured and isobaric
      undiluted levobupivacaine plus 20 µg fentanyl was administered. Afterwards, an epidural
      catheter (Espocan, B.Braun, Melsungen, Germany) wwill be inserted 4 cm into the epidural
      space.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">May 31, 2014</completion_date>
  <primary_completion_date type="Actual">January 1, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hemodynamic continuous monitoring by impedance cardiography</measure>
    <time_frame>intraoperative time</time_frame>
    <description>Impedance cardiography as a tool for hemodynamic monitoring during cesarean section</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>onset of sensory block</measure>
    <time_frame>intraoperative time</time_frame>
    <description>onset time of sensory block after intrathecal levobupivacaine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offset of sensory block</measure>
    <time_frame>intraoperative time</time_frame>
    <description>offset time of sensory block after intrathecal levobupivacaine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>onset of motor block</measure>
    <time_frame>intraoperative time</time_frame>
    <description>onset time of motor block after intrathecal levobupivacaine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>offset of motor block</measure>
    <time_frame>intraoperative time</time_frame>
    <description>offset time of motor block after intrathecal levobupivacaine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>8 mg (2 mL) levobupivacaine</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>8mg (2ml) levobupivacaine plus 20 µg fentanyl will be given intrathecally by spinal anesthesia. The impendance cardiography, the sensory and motor block will be monitored</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6 mg (1.6 mL) levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6mg (1.6ml) levobupivacaine plus 20 µg fentanyl will be given intrathecally by spinal anesthesia. The impendance cardiography, the sensory and motor block will be monitored</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Impedance cardiography</intervention_name>
    <description>hemodynamic variation measured by impedance cardiography in healthy pregnant undergoing to cesarean section treated with 8mg or 6mg of levobupivacaine</description>
    <arm_group_label>8 mg (2 mL) levobupivacaine</arm_group_label>
    <arm_group_label>6 mg (1.6 mL) levobupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Sensory levels</intervention_name>
    <description>Sensory levels are checked using ice test cold</description>
    <arm_group_label>8 mg (2 mL) levobupivacaine</arm_group_label>
    <arm_group_label>6 mg (1.6 mL) levobupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Motor block</intervention_name>
    <description>motor block is measured by modified Bromage scale</description>
    <arm_group_label>8 mg (2 mL) levobupivacaine</arm_group_label>
    <arm_group_label>6 mg (1.6 mL) levobupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Sensory level</intervention_name>
    <description>Sensory levels are checked using touch with alcohol puffs</description>
    <arm_group_label>8 mg (2 mL) levobupivacaine</arm_group_label>
    <arm_group_label>6 mg (1.6 mL) levobupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant undergoing elective Caesarean delivery at term of singleton pregnancy, with
             American Society of Anesthesiologists physical status of class I or II, without
             preeclampsia or diabetes,

        Exclusion Criteria:

          -  Patient with a known allergy to amide local anesthetics and other drugs, with BMI≥40
             kg/m2, cardiologic or systemic disease, in treatment with antihypertensive or
             anticoagulant
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2017</study_first_submitted>
  <study_first_submitted_qc>May 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>October 20, 2017</last_update_submitted>
  <last_update_submitted_qc>October 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Foggia</investigator_affiliation>
    <investigator_full_name>Cotoia Antonella</investigator_full_name>
    <investigator_title>researcher</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

